Table 3.
Characteristics of the patients with BRAFnon-V600E mutations
| Age | Sex | Primary site | Stage | Metastasis site | Histology | RAS status | BRAF status |
|---|---|---|---|---|---|---|---|
| 67 | Female | Rectum | Localized | - | Tub | WT | G466E |
| 74 | Male | Rectum | Localized | - | Tub | WT | G469A |
| 55 | Female | Rectum | Metastatic | Lymph node | Tub | WT | N581T |
| 39 | Female | Rectum | Metastatic | Liver, pleura | Tub | WT | D594G |
| 74 | Male | Rectum | Metastatic | Liver, peritoneum | Tub | WT | D594G |
| 68 | Female | Ascending | Metastatic | Liver | Tub | WT | T599_V600insT |
| 68 | Female | Ascending | Metastatic | Lymph node | Tub | WT | V600R |
| 79 | Female | Ascending | Metastatic | Peritoneum | Tub | WT | K601N |
| 44 | Male | Rectum | Metastatic | Lung | Tub | WT | K601E |
Abbreviations: WT, wild-type; Tub, tubular adenocarcinoma.